DOCSLIB.ORG

Rapid and Accurate Models for Human Disease Studies

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Rapid and Accurate Models for Human Disease Studies ADVERTISEMENT FEATURE ADVERTISEMENT FEATURE Animal Model Resource Rapid and Center, providing facilities for animal model development, accurate models phenotypic analysis, quality testing, species conservation, for human and reproduction. The centre supplies genetically diverse disease studies data resources, patient- derived xenografts, and 865 Researchers at the Institute of Laboratory animal models of both genetic Animal Sciences, Chinese Academy of and non-hereditary diseases, Medical Sciences & Peking Union Medical which include infectious, College, are improving RAPID AND cardiovascular, metabolic, ACCURATE MODEL DEVELOPMENT for and neural diseases, infectious and complex diseases. along with tumours and immunodeficiency. ILAS is also keen to As life sciences and researchers have quickly advance key technologies biomedical research cross developed humanized mice for animal model creation. new frontiers, the need for and monkey models. Their Its National Human Disease animal models is on the rise. studies have assisted with Chuan Qin, ILAS director Animal Model Technology Research into infectious understanding the mechanism Innovation Center takes and complex diseases is and transmission routes of a comparative medicine particularly driving the COVID-19, and developing candidates. In a Science paper risk for recovering COVID-19 protective coats. But the effort co-authored with collaborators and a member organization approach to develop demand for new models that relevant treatment and reporting the study on a patients. In a paper published is worth it, Qin says. “The from Switzerland and France, of the International Council heterogeneous organs are stable and effective. The prevention strategies. purified inactivated vaccine in Science, they demonstrated best reward we get is the wide ILAS scientists detailed an for Laboratory Animal and antibodies based on outbreak of COVID-19 and the As ordinary mice cannot candidate that induced SARS- that monkeys reinfected with use of our animal models in artificial intelligence-powered Science, the Asian Federation humanized animal models, enormous research efforts to be infected with SARS- CoV-2–specific neutralizing the identical SARS-CoV-2 drug and vaccine evaluation brain-spinal cord interface, of Laboratory Animal supported by its phenotypic control it have sharpened this CoV-2, ILAS researchers set antibodies, researchers strain during early recovery studies.” which could enable upright Science Associations, and analysis and preclinical demand. out to genetically engineer showed that immunizations did not show any detectable walking for non-human the International Mouse translational technology Leading responses to these a transgenic mouse model of two vaccine doses clinical manifestations of the Advancing international primates, reducing gait Phenotyping Consortium. platforms. demands are researchers at that includes the humanized provided partial or complete viral disease or signs of viral collaboration abnormalities caused by spinal ILAS is also active in guiding The centre also has a the Institute of Laboratory ACE2 gene, which encodes protection against SARS- dissemination. Comparison Fighting the pandemic injuries. best practices in animal remit to incubate start-ups Animal Sciences (ILAS), part the receptor for SARS- CoV-2 infection in rhesus of cellular immunity between highlights the importance of For that study researchers research, particularly in ethical and talent, supporting drug of the Chinese Academy of CoV-2. Theirs was one of the macaque monkeys. ILAS’s primary infection and collaboration. One element developed rhesus monkey care of laboratory animals. development for major Medical Sciences. Started first of its kind available to animal model development reinfection revealed notably of ILAS’s success has models in which they In 2003, it established the diseases. 40 years ago to fill a national researchers. has supported evaluation of enhanced neutralizing been its establishment of implanted the brain-spine Institutional Animal Care Research resources and gap in laboratory animal ILAS scientists and their adenovirus vector, inactivated, antibody and immune collaborations with leading interface. Wireless control and Use Committee (IACUC) facilities aside, ILAS will studies, ILAS has developed collaborators have since used mRNA, DNA, attenuated, and responses for the latter, institutions worldwide, systems were designed to to push the implementation provide an open environment, into a leading hub for model that model to investigate the recombinant protein vaccines signalling potential protection through which, it has helped to decode the neural signals that of laboratory animal care with interdisciplinary development, teaching, pathogenesis of the virus. In for SARS-CoV-2, explains ILAS against reinfection. drive the fields of comparative govern leg movements and to regulations and guidelines, opportunities to researchers, resource supply and technical one study, published in Nature, director, Chuan Qin, who is a This important work was medicine and neuroscience. translate them into controlled and it was accredited by the complemented by generous services. Focusing on they observed virus replication lead author of the two studies. not easy. ILAS researchers Its exploration of animal movement of paralysed limbs Association for Assessment salaries and benefits. “We comparative medicine, ILAS in the lungs of infected mice, ILAS researchers also had to work in negative air models for nerve injury and using epidural electrical and Accreditation of expect talented scholars in life researchers work across along with weight loss. The used rhesus macaques to pressure cleanrooms for neurodegenerative diseases stimulation. The interface Laboratory Animal Care sciences and biomedicine will disciplines and diseases to study gave evidence that investigate the reinfection long hours, wearing heavy demonstrates its capacity allowed the monkeys to regain International in 2007. be keen to join our efforts of develop models for studies in SARS-CoV-2 is the pathogen for high-level international weight-bearing movements of promoting laboratory animal China and beyond, including responsible for COVID-19, collaboration. the paralysed leg on treadmills Building laboratory animal sciences,” Qin says. SARS-CoV-2. while its pathogenicity To help patients with spinal or the ground, without prior study platforms appeared to be milder than cord-related paralysis, ILAS training. This implant has now One of the most lasting Addressing public health that of SARS-CoV. researchers have, for instance, been approved for testing on contributions to science emergencies In addition to mouse worked with international humans for similar studies. by ILAS could be the When new diseases emerge, models, ILAS teams have neuroscience experts to Active in the international development of new research the rapid development of also created rhesus monkey explore brain-machine academic community, ILAS platforms to broadly enable accurate and useful models models for conducting safety interface (BMI) technologies is the chair organization of biomedical research of www.cnilas.org is vital. Responding to the and efficacy evaluations on ILAS researchers have developed mouse models for studies of SARS-CoV-2 and using animal models. the International Association all sorts. ILAS houses the [email protected] other diseases. 86-(0)10-67776050 SARS-CoV-2 demand, ILAS multiple drug and vaccine In a Nature paper in 2016, for Comparative Medicine, National Human Disease 86-(0)10-67776529 Advertiser retains sole responsibility for content Advertiser retains sole responsibility for content.
Load more

Recommended publications
  • Dear Colleagues, As the Directors of the Bloomington Drosophila Stock
    Dear colleagues, As the directors of the Bloomington Drosophila Stock Center, the national repository for strains of Drosophila melanogaster, we appreciate this opportunity to comment on the proposed redistribution of NCRR Division of Comparative Medicine activities to other NIH entities. In particular, we would like to address the plans to place oversight of non-primate model organism resources within NIGMS. Although we regret the loss of an NIH institute dedicated to research resources, we support the "straw model” plan to relocate the program for non-primate animal models from NCRR to NIGMS. NIGMS is the logical home for this essential activity, because both NIGMS and model organism resource centers support the full breadth of biomedical research—from investigations of fundamental biological processes to disease treatments. Because NCATS will focus primarily on advancing the development of new therapeutics, its mission will not encompass many resource center activities and it should not be expected to evaluate and oversee them. The resource centers strongly promote translational research and the development and use of animal models of human disease, but support of basic research is, and should continue to be, a central part of their mission. Translational research is possible only because a strong foundation of fundamental biological knowledge has been developed through basic research. It is appropriate that the administrative structure of NIH reflects this reality with respect to the oversight of non-primate model organism resources. There are strong synergisms between research supported by NIGMS and the interests of model organism research communities. As the primary funder of basic biomedical research in the U.S., NIGMS has steadfastly supported investigation in fields that underpin translational research such as biochemistry, molecular biology, genetics, developmental biology, physiology, pharmacology, neurobiology and behavior.
    [Show full text]
  • Use of a Single Hybrid Imaging Agent for Integration of Target Validation with in Vivo and Ex Vivo Imaging of Mouse Tumor Lesions Resembling Human DCIS
    Use of a Single Hybrid Imaging Agent for Integration of Target Validation with In Vivo and Ex Vivo Imaging of Mouse Tumor Lesions Resembling Human DCIS The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Buckle, Tessa, Joeri Kuil, Nynke S. van den Berg, Anton Bunschoten, Hildo J. Lamb, Hushan Yuan, Lee Josephson, Jos Jonkers, Alexander D. Borowsky, and Fijs W. B. van Leeuwen. 2013. Use of a single hybrid imaging agent for integration of target validation with in vivo and ex vivo imaging of mouse tumor lesions resembling human DCIS. PLoS ONE 8(1): e48324. Published Version doi:10.1371/journal.pone.0048324 Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:10859968 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA Use of a Single Hybrid Imaging Agent for Integration of Target Validation with In Vivo and Ex Vivo Imaging of Mouse Tumor Lesions Resembling Human DCIS Tessa Buckle1,2, Joeri Kuil1,2, Nynke S. van den Berg1,2, Anton Bunschoten1,2, Hildo J. Lamb3, Hushan Yuan4, Lee Josephson4, Jos Jonkers5, Alexander D. Borowsky6, Fijs W. B. van Leeuwen1,2* 1 Department of Radiology, Interventional Molecular Imaging Laboratory, Leiden University Medical Center, Leiden, The Netherlands, 2 Departments of Radiology and Nuclear Medicine, Netherlands Cancer
    [Show full text]
  • Research – the Institute for Comparative Medicine
    Prospectus – Vet Graduate School The Institute for Comparative Medicine This new Institute has been established as the research division of the School, and to promote an integrated approach to research strategy and planning. The Institute has a strong and diverse research profile much of which is directed towards the fundamental problems common to Veterinary and Medical diseases. Research within the Institute of Comparative Medicine is organised into four themes (Infection and Immunity, Wellcome Centre for Molecular Parasitology, Comparative Pathobiology, Animal Health). These four research themes encompass nine focussed sections that represent the major research activity of the Institute. Resources • Well equipped laboratories • Library • Study areas • PC & On-line access Research Groups Infection and Immunity (Contact: Prof. Andy Tait; [email protected]) Molecular and Immunobiology of Parasitism (Contact Prof. E. Devaney; [email protected]) The research of this group, which includes the Wellcome Centre for Molecular Parasitology (contact Prof. D.Barry; [email protected]), focuses on nematodes and protozoa, and involves molecular and immunological approaches to the understanding of their biology, immune evasion and pathogenesis. The fundamental knowledge which flows from these studies is being applied in the development of novel chemotherapeutics and vaccines. Research on nematodes uses C.elegans as a model system to investigate the development of the cuticle and to analyse the functional roles of key parasite-derived molecules. This research is directed at both the functional analysis of factors determining the expression of environmentally and developmentally regulated genes, as well as parasite regulation of the host immune response.
    [Show full text]
  • COMPARATIVE MEDICINE and VETERINARY SCIENCE APRIL Published Monthly at GARDENVALE, QUE
    Canadian Journal of COMPARATIVE MEDICINE AND VETERINARY SCIENCE APRIL Published Monthly at GARDENVALE, QUE. by NATIONAL BUSINESS PUBLICATIONS, LIMITED EDITORIAL BOARD T. W. M. CAMERON,. T.D.; M.A.; B.Sc. (Vet. Sc.); Ph.D.; D.Sc.; M.R.C.V.S. Director, Institute of Paravitology, Macdonald College, Que. Chas. A. MITCHELL, V.S. B.V.Sc.; D.V.M. Pathologist, Animal Diseases Research Institute, Hull, Que. R. A. McINTOSH, M.D.V.; B.V.Sc. Professor, Diseases of Animals, Obstetrics, Therapeutics, Ontario Veterinary College, Guelph, Ontario. G. T. LABELLE, D.M.V. Inspecteur Vetirinaire senior, Montreal, P. Q. Subscriptions $2.00 per year to qualified veterinarians, libraries, and scientific institutions. Volume 7 Number 4 CONTENTS IDr. A. F. Cameroii, V. 0. G., Retires ....... .............. 97 Dr. E. A. WVatson Retires ......... ................... 98 Obituary-Dr. G. C. Lawrelnce ........ .................. 99 Eiizootic Bovine Haematuria ............ ................ 101 Veterinary Problems from Feeding Coniditions ..... ....... 108 Chastek Paralysis on Alberta Fox Ranbch ...... ............ 112 Implied Warranty of Fitness-Legal Decisioni ..... ....... 114 Current Veteriniary Literature ........ .................. 118 Western Ontario Veterinary Associafioli ........ .......... 123 Book Reviews ..................... ..................... 124 IPUBUAIN IMIbITED ADVERTISING OFFICES:-Head Office:-Gardenvale, Que. Telephone: Ste. Anne de Bellevue 700. Montreal Office:-M. G. Christie, Castle Bldg. Telephone Ma. 9534. Toronto Office:-137 Wellington St., Room 1206, (V. E. Heron). Telephone: Waverley 6206. Vancouver:-F. A. Dun- lop, P. Q. Box 582. Telephone Pacific 2527. New York; W. G. Gould, 7 West 44th Street. Tele- phone, Murray Hill 2-9888 Chicago:-William S. Akin. Suite 512, Mercantile Exchange Bldg., 308 West Washington Street, Telephone: State 8496. San Francisco:- C. H. Woolley, Room 708, 605 Market Street.
    [Show full text]
  • GSA Response to NIH Request for Information On
    Genetics Society of America Response to NIH Request for Information FY 2016-2020 Strategic Plan for the Office of Research Infrastructure Programs: Division of Comparative Medicine and Division of Construction and Instruments Programs Request for Information (NOT-OD-15-056) • Response Form Submitted March 16, 2015 Responses are limited to 1,500 characters per topic. All responses must be submitted by March 16, 2015. Disease Models, Informational Resources, and Other Resources Disease models, informational resources and other resources that should be modified or expanded in parallel with ongoing advances in biomedical research The Genetics Society of America (GSA) emphasizes the importance of model organisms for advancing knowledge in biomedical research. We believe that continued investment in model organisms—and the resources needed for supporting this research—is one of the most effective and efficient ways for NIH to continue to advance our understanding of living systems and improvement in human health. Model organism researchers depend upon shared community resources that serve the entire community, including stock centers and model organism databases, several of which depend upon ORIP funding. The long-term and consistent support of these community resources has been a crucial component of the strength and success of biomedical research in the United States and assures its future vigor. Centralized stock centers and databases provide optimal resource sharing that maximizes the return on the investments made by NIH and other government agencies. These community resources provide “off-the-shelf” research tools and thus increase the efficiency and speed of hypothesis-driven research supported by other grants. In addition, NIH support for these community resources allows them to operate on an open access model, thus assuring that all researchers have the tools they need for discovery.
    [Show full text]
  • Yale Medicine Magazine
    Short-term gains, long-term losses Winter 2020 ALSO 4 FDA approval for Ebola vaccine / 44 Paying it back: Kristina Brown’s quest / 46 The machinery of immune systems Features 12/ Inflammation: part hero, part villain The traditional approach to inflammation is that it’s bad and should be suppressed, but recent findings offer a more nuanced view. By Christopher Hoffman 18/ Studying autoimmunity Researchers hope that the Colton Center for Autoimmunity at Yale will yield results over the next 10 years. By John Curtis 20/ Ketostasis: nature’s sweet spot Glucose plays a complex role in immune system health. By Sonya Collins 24/ Another use for aspirin A versatile remedy also a potential treatment for breast cancer. By John Curtis 26/ Untangling the web of autoimmune disorders When a person develops certain autoimmune disorders, others often follow in their wake. Figuring out why, and how to stop the deterioration, are top priorities for scientists. By Steve Hamm 30/ Why most heads don’t swell Some places in the body don’t suffer from inflammation as a response to intrusion. The brain and spinal cord are among them. By Christopher Hoffman 34/ A new dimension to intestinal surgery One doesn’t often think of the intestines when thinking about how 3D printing can assist with surgery or medicine. John Geibel is looking to change that. By Adrian Bonenberger 36/ Exploring the frontiers of immunity and healing Researchers at Yale are aware of how wounds know to heal. Now they want to know why. By Katherine L. Kraines OTTO STEININGER ILLUSTRATIONS STEININGER OTTO : AGE winter 2020 departments COVER AND OPPOSITE P 2 From the editor / 3 Dialogue / 4 Chronicle / 9 Round Up / 40 Capsule / 42 Faces / 46 Q&A / 48 Books / 49 End Note winter 2020 from the editor volume 54, number 2 Yale’s Actions and Response to Coronavirus (COVID-19) website, covid.yale.edu, provides such information as clinical and laboratory research, patient care, resources to both track Editor the spread of the virus and help cope during this crisis, COVID-19 news, and messages.
    [Show full text]
  • The Vitamin a Story Lifting the Shadow of Death the Vitamin a Story – Lifting the Shadow of Death World Review of Nutrition and Dietetics
    World Review of Nutrition and Dietetics Editor: B. Koletzko Vol. 104 R.D. Semba The Vitamin A Story Lifting the Shadow of Death The Vitamin A Story – Lifting the Shadow of Death World Review of Nutrition and Dietetics Vol. 104 Series Editor Berthold Koletzko Dr. von Hauner Children’s Hospital, Ludwig-Maximilians University of Munich, Munich, Germany Richard D. Semba The Vitamin A Story Lifting the Shadow of Death 41 figures, 2 in color and 9 tables, 2012 Basel · Freiburg · Paris · London · New York · New Delhi · Bangkok · Beijing · Tokyo · Kuala Lumpur · Singapore · Sydney Dr. Richard D. Semba The Johns Hopkins University School of Medicine Baltimore, Md., USA Library of Congress Cataloging-in-Publication Data Semba, Richard D. The vitamin A story : lifting the shadow of death / Richard D. Semba. p. ; cm. -- (World review of nutrition and dietetics, ISSN 0084-2230 ; v. 104) Includes bibliographical references and index. ISBN 978-3-318-02188-2 (hard cover : alk. paper) -- ISBN 978-3-318-02189-9 (e-ISBN) I. Title. II. Series: World review of nutrition and dietetics ; v. 104. 0084-2230 [DNLM: 1. Vitamin A Deficiency--history. 2. History, 19th Century. 3. Night Blindness--history. 4. Vitamin A--therapeutic use. W1 WO898 v.104 2012 / WD 110] 613.2'86--dc23 2012022410 Bibliographic Indices. This publication is listed in bibliographic services, including Current Contents® and PubMed/MEDLINE. Disclaimer. The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publisher and the editor(s). The appearance of advertisements in the book is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety.
    [Show full text]
  • Comparative Medicine Resources
    OFFICE OF RESEARCH INFRASTRUCTURE PROGRAMS FACT SHEET COMPARATIVE SPRING 2017 MEDICINE ORIP MISSION The Office of Research Infrastructure Programs RESOURCES (ORIP) advances the NIH mission by supporting research infrastructure and research-related resources programs, and coordinating NIH’s science education https://orip.nih.gov/comparative-medicine efforts. ORIP’s programs support biomedical researchers with the infrastructure and research- related resources they require to advance medical research and continue improving human health. OVERVIEW Comparative Medicine plays an essential role in biomedical discovery by enabling scientists to better understand, diagnose, prevent, and treat human diseases. Often serving as a bridge between basic science and human medicine, animal models1 have enabled numerous major medical advances—safe and effective vaccines, including Hepatitis A and B immunizations; improved cancer treatments; blood transfusions; organ transplantation; bypass surgery; and joint replacement. Animal • Support phenotypic and genetic characterization models are actively being used to understand the causes of animal models and the development of new and of, and develop therapies for, almost all human conditions, improved long-term storage of animal germ plasm. including cancer, cardiovascular disease, diabetes, obesity, and neurodegenerative and infectious disease. • Support studies aimed at improving the welfare and husbandry of laboratory animals. • The Division of Comparative Medicine (DCM), within the Office of Research Infrastructure Programs (ORIP), • Enable career development and translational research Division of Program Coordination, Planning, and training for veterinary students and veterinarians as well Strategic Initiatives (DCPCSI), National Institutes of as for post-doctoral investigators who use laboratory Health Office of the Director (NIH/OD), works to: animals. • Ensure that NIH-supported researchers have access to, • Increase public-private partnership opportunities with and facilities for, animal models critical to research.
    [Show full text]
  • Identification of Dipeptidase-1 As an Organ-Selective Adhesion Receptor Utilized by Neutrophils and Metastatic Cancer Cells in the Liver and Lungs
    University of Calgary PRISM: University of Calgary's Digital Repository Graduate Studies The Vault: Electronic Theses and Dissertations 2018-04-30 Identification of dipeptidase-1 as an organ-selective adhesion receptor utilized by neutrophils and metastatic cancer cells in the liver and lungs Roy Choudhury, Saurav Roy Choudhury, S. (2018). Identification of dipeptidase-1 as an organ-selective adhesion receptor utilized by neutrophils and metastatic cancer cells in the liver and lungs (Unpublished doctoral thesis). University of Calgary, Calgary, AB. doi:10.11575/PRISM/31901 http://hdl.handle.net/1880/106619 doctoral thesis University of Calgary graduate students retain copyright ownership and moral rights for their thesis. You may use this material in any way that is permitted by the Copyright Act or through licensing that has been assigned to the document. For uses that are not allowable under copyright legislation or licensing, you are required to seek permission. Downloaded from PRISM: https://prism.ucalgary.ca UNIVERSITY OF CALGARY Identification of dipeptidase-1 as an organ-selective adhesion receptor utilized by neutrophils and metastatic cancer cells in the liver and lungs by Saurav Roy Choudhury A THESIS SUBMITTED TO THE FACULTY OF GRADUATE STUDIES IN PARTIAL FULFILMENT OF THE REQUIREMENTS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY GRADUATE PROGRAM IN MEDICAL SCIENCE CALGARY, ALBERTA APRIL, 2018 © Saurav Roy Choudhury 2018 Abstract Lungs and liver are two major sites of neutrophil trafficking and inflammatory disease. Neutrophil recruitment in response to an inflammatory cue is a sequentially coordinated process where adhesion molecules expressed on the endothelium of a given organ mediate different steps in the classical leukocyte recruitment cascade [1].
    [Show full text]
  • Comparative Medicine in Ancient Egypt: Origins of Early Biomedical Theories
    Comparative Medicine in Ancient Egypt: Origins of Early Biomedical Theories Calvin W. Schwabe In introducing today's lecture let me repeat for any of you without medical backgrounds that epidemiology is the study of diseases in populations. It is the one diagnostic approach which is unique to the practice of medicine at herd or other population levels. Of the 3 main facets of epidemiological diagnosis-- disease intelligence, medical ecology and quantitative analysis-- portions of the first two have often been referred to popularly as "disease sleuthing" or medical detective work. Many of you are familiar with the fascinating yet factual narratives about inquiries into the patterns and behavior of diseases new and old which were written over a many year period for the New Yorker magazine by Berton Rouché, a very talented reporter of science who died just a few weeks ago. Many of those narratives were also collected into several absorbing books about the work of epidemiologists as medical detectives. I drew yesterday upon my long interests in more systematized information-gathering for disease control efforts to indicate how veterinary services delivery in Africa could prove the vital key to initiation and facilitation of successful development approaches among that continent's tens of millions of migratory pastoralists, peoples whose plights in the southern Sudan, Somalia, Ethiopia, Rwanda, the Sahel and elsewhere in Africa intrude upon our living room TV screens every now and again. Today I am going to introduce aspects of a very different but interestingly related type of medical detective work which I have managed since the 1950s to "piggyback" logistically upon those other development-related activities in Africa.
    [Show full text]
  • The Palgrave Handbook of the History of Surgery
    THE PALGRAVE HANDBOOK OF THE HISTORY OF SURGERY Edited by Thomas Schlich The Palgrave Handbook of the History of Surgery Thomas Schlich Editor The Palgrave Handbook of the History of Surgery Editor Thomas Schlich Department of Social Studies of Medicine McGill University Montreal, QC, Canada ISBN 978-1-349-95259-5 ISBN 978-1-349-95260-1 (eBook) https://doi.org/10.1057/978-1-349-95260-1 Library of Congress Control Number: 2017944555 © The Editor(s) (if applicable) and The Author(s) 2018 The author(s) has/have asserted their right(s) to be identifed as the author(s) of this work in accordance with the Copyright, Designs and Patents Act 1988. The chapters ‘Surgery and Emotion: The Era Before Anaesthesia’ and ‘Surgery, Imperial Rule and Colonial Societies (1800–1930): Technical, Institutional and Social Histories’ are licensed under the terms of the Creative Commons Attribution 4.0 International License (http:// creativecommons.org/licenses/by/4.0/). For further details see license information in the chapters. This work is subject to copyright. All rights are solely and exclusively licensed by the Publisher, whether the whole or part of the material is concerned, specifcally the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microflms or in any other physical way, and transmission or information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed. The use of general descriptive names, registered names, trademarks, service marks, etc. in this publication does not imply, even in the absence of a specifc statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use.
    [Show full text]
  • The CV Is Impressive, Even by Hopkins' Demanding Standards. Co
    Current Issue Past Issues Talk to Us About the Magazine Search Adams shares a treat with a baboon, one of 450 primates that fall under his veterinary care at Hopkins. By putting animals’ welfare first, top vet Bob Adams has become a powerful ally to the scientific enterprise—and the “go-to” guy for researchers across the medical campus. BY MAT EDELSON PHOTOGRAPY BY KEITH WELLER The CV is impressive, even by Hopkins’ demanding standards. Co-authorship on 67 papers, touching on nearly every facet of biomedical research: Journal of Infectious Diseases, Journal of Rheumatology, Science, Circulation, Neurotoxicology … to name but a few. A quarter-century as director of a division intimately involved with many of the scientific advances at Hopkins: Potential cures for paralysis. Discovering the pathways that lead to the neurological devastation of AIDS. Understanding the addictive properties of drugs. Then there’s the surgical wizardry, testament to his colleagues’ claims that he’s a technical marvel whose knowledge of anatomy is without peer. All this, and the man does not possess an M.D. Nor, for that matter, a Ph.D. Or an Sc.D., M.P.H., or any other of the alphabet soup of advanced degrees so common to Hopkins researchers. So who the heck is Bob Adams? He’s a veterinarian. And his work is helping to change the face of human medicine. ***** Cardiac surgery fellow Lois U. Nwakanma, M.D., has hit a brick wall, and so she’s turned to Robert J. Adams, D.V.M. (Doctor of Veterinary Medicine), this autumn afternoon for guidance.
    [Show full text]